Free Trial
NYSE:MTNB

Matinas Biopharma 5/10/2023 Earnings Report

Matinas Biopharma logo
$1.03 +0.04 (+4.04%)
Closing price 04:00 PM Eastern
Extended Trading
$1.00 -0.03 (-3.30%)
As of 06:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Matinas Biopharma EPS Results

Actual EPS
-$0.03
Consensus EPS
-$0.03
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Matinas Biopharma Revenue Results

Actual Revenue
$1.10 million
Expected Revenue
$0.30 million
Beat/Miss
Beat by +$800.00 thousand
YoY Revenue Growth
N/A

Matinas Biopharma Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Matinas Biopharma Earnings Headlines

MTNB Matinas BioPharma Holdings, Inc. - Seeking Alpha
Matinas BioPharma Holdings, Inc. (MTNB) - Yahoo Finance
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
Matinas BioPharma files to sell 16.9M shares of common stock for holders
See More Matinas Biopharma Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Matinas Biopharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Matinas Biopharma and other key companies, straight to your email.

About Matinas Biopharma

Matinas Biopharma (NYSE:MTNB) is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.

View Matinas Biopharma Profile

More Earnings Resources from MarketBeat